The Science of Cannabis: Does It Help or Hurt With Anxiety? Is It Addictive? What's the Safest Way To Use It? | Dr. Riley Kirk

What It Covers

Dr. Riley Kirk explains cannabis science, covering THC versus CBD differences, endocannabinoid system function, evidence-based medical applications, anxiety management strategies, safe dosing protocols, consumption methods, adolescent risks, and navigating legal markets.

Key Questions Answered

• •THC Dosing Paradox: THC works biphasically - low microdoses reduce anxiety while high doses (like 25% THC joints) trigger panic attacks. CBD at 200mg or higher protects against THC overstimulation by balancing brain receptors, making CBD-dominant hemp flower safer for anxiety-prone users than pure THC products.
• •Endocannabinoid System Function: Every human possesses an endocannabinoid system that regulates sleep, appetite, pain, and mood through cannabinoid receptors CB1 and CB2. Cannabis compounds mimic endogenous cannabinoids to restore homeostasis when body systems become dysregulated, explaining why cannabis treats diverse conditions from seizures to inflammation.
• •Edible Effectiveness Limitation: Twenty percent of people cannot feel edibles due to genetic variations in liver enzymes that process THC. These individuals can consume 1000mg THC without effects. Sublingual tinctures bypass liver metabolism, offering an alternative delivery method for those with enzyme deficiencies affecting edible absorption.
• •Adolescent Brain Risks: Modern vape cartridges contain up to 98% THC versus historical cannabis at 10% THC. Young users consuming high-potency vapes face unknown developmental risks including altered gray-to-white matter ratios in developing brains. Lower-dose hemp flower with balanced CBD-THC ratios presents safer options for harm reduction.
• •Medical Dosing Standards: Research supports 200mg CBD minimum for anxiety and seizure treatment, yet most commercial products contain only 5-10mg CBD. Epidiolex pharmaceutical uses pure CBD for severe seizures, while Marinol THC treats HIV/AIDS appetite loss and chronic pain, demonstrating evidence-based therapeutic dosing requirements.